Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;44(10):2078-2088.
doi: 10.1002/jssc.202100050. Epub 2021 Apr 9.

Identification and characterization of Prothionamide degradation impurities by mass spectrometry, NMR spectroscopy, and ultra high performance liquid chromatography method development

Affiliations

Identification and characterization of Prothionamide degradation impurities by mass spectrometry, NMR spectroscopy, and ultra high performance liquid chromatography method development

Vijaya Kumar Baksam et al. J Sep Sci. 2021 May.

Abstract

Stability-indicating and liquid chromatography-mass spectrometry compatible ultra high performance liquid chromatography method was developed for the degradation and drug substances related impurities of Prothionamide. Forced degradation of Prothionamide was carried out under acidic, basic, thermal, oxidative, and photolytic stress conditions. The impurities separation was achieved on Acquity UPLC BEH-C18 (50 mm × 2.1 mm, 1.7 μm) with the mobile phase of 10 mm ammonium acetate pH 6.0 and Acetonitrile in a time gradient mode. Related substances by ultra-performance liquid chromatography method was validated according to ICH tripartite guidelines. Degradation products were isolated by Column chromatography and characterized by liquid chromatography-mass spectrometry, 1 H, and 13 C nuclear magnetic resonance spectroscopy. The developed related substances method showed adequate specificity, sensitivity, accuracy, linearity (0.4-1.5 μg/mL), precision, and robustness in line with ICH tripartite guidelines for validation of analytical procedures. Limits of detection and quantitation were 0.1 and 0.4 μg/mL, respectively, for Prothionamide and all the impurities. The method was found to be linear with a correlation coefficient > 0.99, precise (%RSD < 5.0), robust and accurate (%recovery 85-115%).

Keywords: degradation impurities; method validation; prothionamide; stress conditions; structural elucidation.

PubMed Disclaimer

References

REFERENCES

    1. Prothionamide. Tuberculosis. 2008, 88(2), 139-40.
    1. Feng W., Robert L., Gulcin G., Lynn G., Gurdyal S., William R., Jacobs Jr., James C., Mechanism of thioamide drug action against tuberculosis and leprosy. J. Exp. Med. 2007, 204, 73-8.
    1. Thee S., Garcia P., Donald P., Hesseling A., Schaaf H., A review of the use of ethionamide and prothionamide in childhood tuberculosis. Tuberculosis. 2016, 97, 126-36.
    1. Fajardo T., Guinto R., Cellona R., Abalos R., Dela C., Gelber R., A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy. Am. J. Trop. Med. Hyg. 2006, 74, 457-61.
    1. Venkatesan K., Clinical pharmacokinetic considerations in the treatment of patients with leprosy. Clin. Pharmacokinet. 1989, 16, 365-86.

Publication types

MeSH terms

LinkOut - more resources